ADI vs. KNSA
ADI (Analog Devices, Inc.) and KNSA (Kiniksa Pharmaceuticals, Ltd.) are both stocks. ADI operates in Semiconductors (Technology), while KNSA operates in Biotechnology (Healthcare). Over the past 5 years, ADI returned 23.86%/yr vs 29.69%/yr for KNSA. At a 0.22 correlation, their price movements are largely independent.
Performance
ADI vs. KNSA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ADI achieves a 61.14% return, which is significantly higher than KNSA's 33.60% return.
ADI
- 1D
- 4.83%
- 1M
- 13.39%
- YTD
- 61.14%
- 6M
- 59.24%
- 1Y
- 92.81%
- 3Y*
- 34.28%
- 5Y*
- 23.86%
- 10Y*
- 24.89%
KNSA
- 1D
- 1.66%
- 1M
- 3.51%
- YTD
- 33.60%
- 6M
- 27.60%
- 1Y
- 93.78%
- 3Y*
- 52.43%
- 5Y*
- 29.69%
- 10Y*
- —
ADI vs. KNSA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ADI Analog Devices, Inc. | 61.14% | 29.75% | 8.82% | 23.36% | -4.91% | 20.96% | 26.87% | 41.31% | -7.70% |
KNSA Kiniksa Pharmaceuticals, Ltd. | 33.60% | 108.54% | 12.77% | 17.09% | 27.27% | -33.39% | 59.76% | -60.63% | 14.89% |
Correlation
The correlation between ADI and KNSA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 24, 2018 | 0.22 |
The correlation between ADI and KNSA shifts across timeframes, from 0.08 (1 year) to 0.23 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ADI:
$213.08B
KNSA:
$4.54B
ADI:
$6.72
KNSA:
$0.92
ADI:
64.65
KNSA:
59.85
ADI:
3.98
KNSA:
0.58
ADI:
16.81
KNSA:
5.80
ADI:
6.32
KNSA:
7.50
ADI:
$12.74B
KNSA:
$754.05M
ADI:
$8.22B
KNSA:
$294.06M
ADI:
$6.19B
KNSA:
$101.06M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADI vs. KNSA — Risk / Return Rank
ADI
KNSA
ADI vs. KNSA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Analog Devices, Inc. (ADI) and Kiniksa Pharmaceuticals, Ltd. (KNSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ADI | KNSA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.59 | ||
| Sortino ratioReturn per unit of downside risk | +0.35 | ||
| Omega ratioGain probability vs. loss probability | 1.46 | 1.41 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 5.86 | 4.63 | +1.23 |
| Martin ratioReturn relative to average drawdown | 16.11 | 16.35 | -0.24 |
Loading charts...
Drawdowns
ADI vs. KNSA - Drawdown Comparison
The maximum ADI drawdown since its inception was -82.88%, roughly equal to the maximum KNSA drawdown of -83.06%. Use the drawdown chart below to compare losses from any high point for ADI and KNSA.
Loading charts...
Drawdown Indicators
| ADI | KNSA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.88% | -83.06% | +0.18% |
Max Drawdown (1Y)Largest decline over 1 year | -15.73% | -21.12% | +5.39% |
Max Drawdown (3Y)Largest decline over 3 years | -32.20% | -34.14% | +1.94% |
Max Drawdown (5Y)Largest decline over 5 years | -32.20% | -53.17% | +20.97% |
Max Drawdown (10Y)Largest decline over 10 years | -33.62% | — | — |
Current DrawdownCurrent decline from peak | -0.73% | -7.35% | +6.62% |
Average DrawdownAverage peak-to-trough decline | -33.90% | -40.60% | +6.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.71% | 5.97% | -0.26% |
Volatility
ADI vs. KNSA - Volatility Comparison
Analog Devices, Inc. (ADI) has a higher volatility of 15.74% compared to Kiniksa Pharmaceuticals, Ltd. (KNSA) at 10.40%. This indicates that ADI's price experiences larger fluctuations and is considered to be riskier than KNSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADI | KNSA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.74% | 10.40% | +5.34% |
Volatility (6M)Calculated over the trailing 6-month period | 25.86% | 34.02% | -8.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.18% | 43.03% | -10.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.22% | 53.48% | -20.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.83% | 63.93% | -31.10% |
Dividends
ADI vs. KNSA - Dividend Comparison
ADI's dividend yield for the trailing twelve months is around 0.96%, while KNSA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADI Analog Devices, Inc. | 0.96% | 1.46% | 1.73% | 1.73% | 1.85% | 1.57% | 1.68% | 1.82% | 2.24% | 2.02% | 2.31% | 2.89% |
KNSA Kiniksa Pharmaceuticals, Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ADI vs. KNSA - Financials Comparison
This section allows you to compare key financial metrics between Analog Devices, Inc. and Kiniksa Pharmaceuticals, Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ADI vs. KNSA - Profitability Comparison
ADI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported a gross profit of 2.44B and revenue of 3.62B. Therefore, the gross margin over that period was 67.3%.
KNSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.
ADI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported an operating income of 1.38B and revenue of 3.62B, resulting in an operating margin of 38.1%.
KNSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.
ADI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported a net income of 1.18B and revenue of 3.62B, resulting in a net margin of 32.5%.
KNSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.
Frequently Asked Questions
ADI and KNSA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ADI has higher volatility (15.74%) compared to KNSA (10.40%). In terms of maximum drawdown, ADI dropped -82.88% vs KNSA's -83.06%.
ADI currently has the higher Sharpe Ratio (2.87 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ADI and KNSA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer